Dysregulated miR-103 and miR-143 expression in peripheral blood mononuclear cells from induced prediabetes and type 2 diabetes rats

Gene

Volumn 572, Issue 1, 2015, Pages 95-100

  Vatandoost, Nasimeh ^a   Amini, Masoud ^b   Iraj, Bijan ^b   Momenzadeh, Sedigheh ^a   Salehi, Rasoul ^a  

^a ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

MicroRNA; Noninvasive diagnosis; PBMCs; Type 2 diabetes (T2D)

Indexed keywords

GLUCOSE; INSULIN; MICRORNA; MICRORNA 103; MICRORNA 143; STREPTOZOCIN; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; GENETIC MARKER; MIRN103 MICRORNA, RAT; MIRN143 MICRORNA, RAT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; GLUCOSE BLOOD LEVEL; IMPAIRED GLUCOSE TOLERANCE; INSULIN BLOOD LEVEL; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NON INVASIVE MEASUREMENT; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; RAT; REAL TIME POLYMERASE CHAIN REACTION; RNA ANALYSIS; TRIACYLGLYCEROL BLOOD LEVEL; ADVERSE EFFECTS; ANIMAL; BLOOD; EXPERIMENTAL DIABETES MELLITUS; GENE EXPRESSION REGULATION; GENETIC MARKER; GENETICS; HUMAN; LIPID DIET; METABOLISM; MONONUCLEAR CELL; WISTAR RAT;

ANIMALS; BIOMARKERS; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 2; DIET, HIGH-FAT; DISEASE PROGRESSION; GENE EXPRESSION REGULATION; GENETIC MARKERS; HUMANS; LEUKOCYTES, MONONUCLEAR; MALE; MICRORNAS; PREDIABETIC STATE; RATS; RATS, WISTAR;

EID: 84940475680     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2015.07.015     Document Type: Article

References (63)

1. Abdul-Ghani M.A., DeFronzo R.A. Pathophysiology of prediabetes. Curr. Diab. Rep. 2009, 9:193-199.
2. Ambros V. The functions of animal microRNAs. Nature 2004, 431:350-355.
3. Aravin A., Tuschl T. Identification and characterization of small RNAs involved in RNA silencing. FEBS Lett. 2005, 579:5830-5840.
4. Bartel D.P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004, 116:281-297.
5. Bartel D.P. MicroRNAs: target recognition and regulatory functions. Cell 2009, 136:215-233.
6. Behm-Ansmant I., Rehwinkel J., Izaurralde E. MicroRNAs silence gene expression by repressing protein expression and/or by promoting mRNA decay. Cold Spring Harb. Symp. Quant. Biol. 2006, 71:523-530.
7. Billings L.K., Florez J.C. The genetics of type 2 diabetes: what have we learned from GWAS?. Ann. N. Y. Acad. Sci. 2010, 1212:59-77.
8. Chen X., Ba Y., Ma L., Cai X., Yin Y., Wang K., Guo J., Zhang Y., Chen J., Guo X., et al. Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res. 2008, 18:997-1006.
9. Collares C.V., Evangelista A.F., Xavier D.J., Rassi D.M., Arns T., Foss-Freitas M.C., Foss M.C., Puthier D., Sakamoto-Hojo E.T., Passos G.A., Donadi E.A. Identifying common and specific microRNAs expressed in peripheral blood mononuclear cell of type 1, type 2, and gestational diabetes mellitus patients. BMC Res. Notes 2013, 6:491.
10. Corral-Fernandez N.E., Salgado-Bustamante M., Martinez-Leija M.E., Cortez-Espinosa N., Garcia-Hernandez M.H., Reynaga-Hernandez E., Quezada-Calvillo R., Portales-Perez D.P. Dysregulated miR-155 expression in peripheral blood mononuclear cells from patients with type 2 diabetes. Exp. Clin. Endocrinol. Diabetes 2013, 121:347-353.
11. Dweep H., Sticht C., Pandey P., Gretz N. miRWalk-database: prediction of possible miRNA binding sites by "walking" the genes of three genomes. J. Biomed. Inform. 2011, 44:839-847.
12. Engels B.M., Hutvagner G. Principles and effects of microRNA-mediated post-transcriptional gene regulation. Oncogene 2006, 25:6163-6169.
13. Esau C., Kang X., Peralta E., Hanson E., Marcusson E.G., Ravichandran L.V., Sun Y., Koo S., Perera R.J., Jain R., et al. MicroRNA-143 regulates adipocyte differentiation. J. Biol. Chem. 2004, 279:52361-52365.
14. Esguerra J.L., Bolmeson C., Cilio C.M., Eliasson L. Differential glucose-regulation of microRNAs in pancreatic islets of non-obese type 2 diabetes model Goto-Kakizaki rat. PLoS One 2011, 6:e18613.
15. Frampton A.E., Fletcher C.E., Gall T.M., Castellano L., Bevan C.L., Stebbing J., Krell J. Circulating peripheral blood mononuclear cells exhibit altered miRNA expression patterns in pancreatic cancer. Expert. Rev. Mol. Diagn. 2013, 13:425-430.
16. Gerich J.E. The genetic basis of type 2 diabetes mellitus: impaired insulin secretion versus impaired insulin sensitivity. Endocr. Rev. 1998, 19:491-503.
17. Ha T.Y. MicroRNAs in human diseases: from cancer to cardiovascular disease. Immune Netw. 2011, 11:135-154.
18. He A., Zhu L., Gupta N., Chang Y., Fang F. Overexpression of micro ribonucleic acid 29, highly up-regulated in diabetic rats, leads to insulin resistance in 3T3-L1 adipocytes. Mol. Endocrinol. 2007, 21:2785-2794.
19. Herder C., Karakas M., Koenig W. Biomarkers for the prediction of type 2 diabetes and cardiovascular disease. Clin. Pharmacol. Ther. 2011, 90:52-66.
20. Herrera B.M., Lockstone H.E., Taylor J.M., Wills Q.F., Kaisaki P.J., Barrett A., Camps C., Fernandez C., Ragoussis J., Gauguier D., et al. MicroRNA-125a is over-expressed in insulin target tissues in a spontaneous rat model of type 2 diabetes. BMC Med. Genomics 2009, 2:54.
21. Herrera B.M., Lockstone H.E., Taylor J.M., Ria M., Barrett A., Collins S., Kaisaki P., Argoud K., Fernandez C., Travers M.E., et al. Global microRNA expression profiles in insulin target tissues in a spontaneous rat model of type 2 diabetes. Diabetologia 2010, 53:1099-1109.
22. Hoekstra M., van der Lans C.A., Halvorsen B., Gullestad L., Kuiper J., Aukrust P., van Berkel T.J., Biessen E.A. The peripheral blood mononuclear cell microRNA signature of coronary artery disease. Biochem. Biophys. Res. Commun. 2010, 394:792-797.
23. Hunter M.P., Ismail N., Zhang X., Aguda B.D., Lee E.J., Yu L., Xiao T., Schafer J., Lee M.L., Schmittgen T.D., et al. Detection of microRNA expression in human peripheral blood microvesicles. PLoS One 2008, 3:e3694.
24. Iguchi H., Kosaka N., Ochiya T. Secretory microRNAs as a versatile communication tool. Commun. Integr. Biol. 2010, 3:478-481.
25. Jin W., Goldfine A.B., Boes T., Henry R.R., Ciaraldi T.P., Kim E.Y., Emecan M., Fitzpatrick C., Sen A., Shah A., et al. Increased SRF transcriptional activity in human and mouse skeletal muscle is a signature of insulin resistance. J. Clin. Invest. 2011, 121:918-929.
26. John B., Enright A.J., Aravin A., Tuschl T., Sander C., Marks D.S. Human microRNA targets. PLoS Biol. 2004, 2:e363.
27. Jordan S.D., Kruger M., Willmes D.M., Redemann N., Wunderlich F.T., Bronneke H.S., Merkwirth C., Kashkar H., Olkkonen V.M., Bottger T., et al. Obesity-induced overexpression of miRNA-143 inhibits insulin-stimulated AKT activation and impairs glucose metabolism. Nat. Cell Biol. 2011, 13:434-446.
28. Karolina D.S., Armugam A., Tavintharan S., Wong M.T., Lim S.C., Sum C.F., Jeyaseelan K. MicroRNA 144 impairs insulin signaling by inhibiting the expression of insulin receptor substrate 1 in type 2 diabetes mellitus. PLoS One 2011, 6:e22839.
29. Keller A., Leidinger P., Borries A., Wendschlag A., Wucherpfennig F., Scheffler M., Huwer H., Lenhof H.P., Meese E. miRNAs in lung cancer - studying complex fingerprints in patient's blood cells by microarray experiments. BMC Cancer 2009, 9:353.
30. Kloosterman W.P., Plasterk R.H. The diverse functions of microRNAs in animal development and disease. Dev. Cell 2006, 11:441-450.
31. Kong L., Zhu J., Han W., Jiang X., Xu M., Zhao Y., Dong Q., Pang Z., Guan Q., Gao L., et al. Significance of serum microRNAs in pre-diabetes and newly diagnosed type 2 diabetes: a clinical study. Acta Diabetol. 2011, 48:61-69.
32. Kosaka N., Iguchi H., Yoshioka Y., Takeshita F., Matsuki Y., Ochiya T. Secretory mechanisms and intercellular transfer of microRNAs in living cells. J. Biol. Chem. 2010, 285:17442-17452.
33. Lewis B.P., Burge C.B., Bartel D.P. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 2005, 120:15-20.
34. Li S., Chen X., Zhang H., Liang X., Xiang Y., Yu C., Zen K., Li Y., Zhang C.Y. Differential expression of microRNAs in mouse liver under aberrant energy metabolic status. J. Lipid Res. 2009, 50:1756-1765.
35. Ling H.Y., Ou H.S., Feng S.D., Zhang X.Y., Tuo Q.H., Chen L.X., Zhu B.Y., Gao Z.P., Tang C.K., Yin W.D., et al. CHANGES IN microRNA (miR) profile and effects of miR-320 in insulin-resistant 3T3-L1 adipocytes. Clin. Exp. Pharmacol. Physiol. 2009, 36:e32-e39.
36. Lu M., Zhang Q., Deng M., Miao J., Guo Y., Gao W., Cui Q. An analysis of human microRNA and disease associations. PLoS One 2008, 3:e3420.
37. Lyssenko V., Jonsson A., Almgren P., Pulizzi N., Isomaa B., Tuomi T., Berglund G., Altshuler D., Nilsson P., Groop L. Clinical risk factors, DNA variants, and the development of type 2 diabetes. N. Engl. J. Med. 2008, 359:2220-2232.
38. Mohr S., Liew C.C. The peripheral-blood transcriptome: new insights into disease and risk assessment. Trends Mol. Med. 2007, 13:422-432.
39. Muoio D.M., Newgard C.B. Mechanisms of disease: molecular and metabolic mechanisms of insulin resistance and beta-cell failure in type 2 diabetes. Nat. Rev. Mol. Cell Biol. 2008, 9:193-205.
40. Pandey A.K., Agarwal P., Kaur K., Datta M. MicroRNAs in diabetes: tiny players in big disease. Cell. Physiol. Biochem. 2009, 23:221-232.
41. Poy M.N., Eliasson L., Krutzfeldt J., Kuwajima S., Ma X., Macdonald P.E., Pfeffer S., Tuschl T., Rajewsky N., Rorsman P., Stoffel M. A pancreatic islet-specific microRNA regulates insulin secretion. Nature 2004, 432:226-230.
42. Reed M.J., Meszaros K., Entes L.J., Claypool M.D., Pinkett J.G., Gadbois T.M., Reaven G.M. A new rat model of type 2 diabetes: the fat-fed, streptozotocin-treated rat. Metabolism 2000, 49:1390-1394.
43. Romao I., Roth J. Genetic and environmental interactions in obesity and type 2 diabetes. J. Am. Diet. Assoc. 2008, 108:S24-S28.
44. Rottiers V., Najafi-Shoushtari S.H., Kristo F., Gurumurthy S., Zhong L., Li Y., Cohen D.E., Gerszten R.E., Bardeesy N., Mostoslavsky R., Naar A.M. MicroRNAs in metabolism and metabolic diseases. Cold Spring Harb. Symp. Quant. Biol. 2011, 76:225-233.
45. Sanghera D.K., Blackett P.R. Type 2 diabetes genetics: beyond GWAS. J. Diabetes Metab. 2012, 3.
46. Schlienger J.L. Type 2 diabetes complications. Presse Med. 2013, 42:839-848.
47. Selbach M., Schwanhausser B., Thierfelder N., Fang Z., Khanin R., Rajewsky N. Widespread changes in protein synthesis induced by microRNAs. Nature 2008, 455:58-63.
48. Shantikumar S., Caporali A., Emanueli C. Role of microRNAs in diabetes and its cardiovascular complications. Cardiovasc. Res. 2012, 93:583-593.
49. Sharifi M., Salehi R., Gheisari Y., Kazemi M. Inhibition of microRNA miR-92a induces apoptosis and necrosis in human acute promyelocytic leukemia. Adv. Biomed. Res. 2014, 3:61.
50. Simons M., Raposo G. Exosomes-vesicular carriers for intercellular communication. Curr. Opin. Cell Biol. 2009, 21:575-581.
51. Srinivasan K., Viswanad B., Asrat L., Kaul C.L., Ramarao P. Combination of high-fat diet-fed and low-dose streptozotocin-treated rat: a model for type 2 diabetes and pharmacological screening. Pharmacol. Res. 2005, 52:313-320.
52. Tang X., Muniappan L., Tang G., Ozcan S. Identification of glucose-regulated miRNAs from pancreatic {beta} cells reveals a role for miR-30d in insulin transcription. RNA 2009, 15:287-293.
53. Trajkovski M., Hausser J., Soutschek J., Bhat B., Akin A., Zavolan M., Heim M.H., Stoffel M. MicroRNAs 103 and 107 regulate insulin sensitivity. Nature 2011, 474:649-653.
54. Valadi H., Ekstrom K., Bossios A., Sjostrand M., Lee J.J., Lotvall J.O. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat. Cell Biol. 2007, 9:654-659.
55. van Iterson M., Bervoets S., de Meijer E.J., Buermans H.P., t Hoen P.A., Menezes R.X., Boer J.M. Integrated analysis of microRNA and mRNA expression: adding biological significance to microRNA target predictions. Nucleic Acids Res. 2013, 41:e146.
56. Wang Y., Wang P.Y., Qin L.Q., Davaasambuu G., Kaneko T., Xu J., Murata S., Katoh R., Sato A. The development of diabetes mellitus in Wistar rats kept on a high-fat/low-carbohydrate diet for long periods. Endocrine 2003, 22:85-92.
57. Whiting D.R., Guariguata L., Weil C., Shaw J. IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Res. Clin. Pract. 2011, 94:311-321.
58. Wilfred B.R., Wang W.X., Nelson P.T. Energizing miRNA research: a review of the role of miRNAs in lipid metabolism, with a prediction that miR-103/107 regulates human metabolic pathways. Mol. Genet. Metab. 2007, 91:209-217.
59. Xie X., Lu J., Kulbokas E.J., Golub T.R., Mootha V., Lindblad-Toh K., Lander E.S., Kellis M. Systematic discovery of regulatory motifs in human promoters and 3' UTRs by comparison of several mammals. Nature 2005, 434:338-345.
60. Xie H., Lim B., Lodish H.F. MicroRNAs induced during adipogenesis that accelerate fat cell development are downregulated in obesity. Diabetes 2009, 58:1050-1057.
61. Zampetaki A., Kiechl S., Drozdov I., Willeit P., Mayr U., Prokopi M., Mayr A., Weger S., Oberhollenzer F., Bonora E., et al. Plasma microRNA profiling reveals loss of endothelial miR-126 and other microRNAs in type 2 diabetes. Circ. Res. 2010, 107:810-817.
62. Zeng X.L., Zhang S.Y., Zheng J.F., Yuan H., Wang Y. Altered miR-143 and miR-150 expressions in peripheral blood mononuclear cells for diagnosis of non-small cell lung cancer. Chin. Med. J. (Engl.) 2013, 126:4510-4516.
63. Zhao E., Keller M.P., Rabaglia M.E., Oler A.T., Stapleton D.S., Schueler K.L., Neto E.C., Moon J.Y., Wang P., Wang I.M., et al. Obesity and genetics regulate microRNAs in islets, liver, and adipose of diabetic mice. Mamm. Genome 2009, 20:476-485.